Outcome After Lumbar Epidural Steroid Injection

NCT01079026 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2010-03-02

No results posted yet for this study

Summary

prospectively validate a fibronectin-aggrecan complex as a biomarker for response to ESI for radiculopathy with HNP

Conditions

  • Disc Disease

Sponsors & Collaborators

  • Cytonics Corporation

    collaborator INDUSTRY
  • Scuderi, Gaetano J., M.D.

    lead OTHER

Principal Investigators

  • Gaetano J Scuderi, MD · Stanford University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-03-31
Completion
2010-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01079026 on ClinicalTrials.gov